India’s Largest Drugmaker Starts Trials for Plant-Based Covid-19 Drug
Employees enter Sun Pharma’s corporate office in the Andheri suburb of Mumbai, India. (Photographer: Amit Madheshiya/Bloomberg)

India’s Largest Drugmaker Starts Trials for Plant-Based Covid-19 Drug

(Bloomberg) -- Sun Pharmaceutical Industries Ltd. has launched clinical trials of a plant-derived drug it’s developing to treat Covid-19, joining the race to find an effective treatment for the dis...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.